FKACX
Price
$27.67
Change
-$0.48 (-1.71%)
Updated
Jul 13 closing price
Net Assets
4.59B
RGACX
Price
$82.84
Change
-$1.34 (-1.59%)
Updated
Jul 13 closing price
Net Assets
356.86B
Interact to see
Advertisement

FKACX vs RGACX

FKACX vs RGACX Comparison Chart in %
View a ticker or compare two or three
VS
FKACX vs. RGACX commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FKACX is a Buy and RGACX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGACX has more cash in the bank: 357B vs. FKACX (4.59B). FKACX (0.00) and RGACX (0.00) have matching dividends . FKACX was incepted earlier than RGACX: FKACX (27 years) vs RGACX (24 years). FKACX (1.64) is less costly to investors than RGACX (0.93). RGACX is a more actively managed with annual turnover of: 32.00 vs. FKACX (27.59). RGACX has a lower initial minimum investment than FKACX: RGACX (250) vs FKACX (1000). RGACX annual gain was more profitable for investors over the last year : 3.68 vs. FKACX (-15.39). RGACX return over 5 years is better than : 13.46 vs. FKACX (-41.05).
FKACXRGACXFKACX / RGACX
Total Expense Ratio1.640.93176%
Annual Report Gross Expense Ratio1.640.93176%
Fund Existence27 years24 years-
Gain YTD9.3206.959134%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets4.59B357B1%
Annual Yield % from dividends0.000.00-
Returns for 1 year-15.393.68-418%
Returns for 3 years-14.2837.13-38%
Returns for 5 years-41.0513.46-305%
Returns for 10 years2.8597.583%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HP33.970.64
+1.92%
Helmerich & Payne
AKA11.18N/A
N/A
aka Brands Holding Corp
LH276.68-0.13
-0.05%
Laboratory Corp
SABR1.76-0.09
-4.86%
Sabre Corp
ERNA5.54-0.52
-8.58%
Ernexa Therapeutics Inc.